Daito Pharms Co Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DAITO PHARMS CO LTD, and what generic and branded alternatives to DAITO PHARMS CO LTD drugs are available?
DAITO PHARMS CO LTD has one approved drug.
Summary for Daito Pharms Co Ltd
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Daito Pharms Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daito Pharms Co Ltd | RILUZOLE | riluzole | TABLET;ORAL | 204430-001 | Oct 16, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
